Nathan Yee

Nathan Yee Email and Phone Number

Vice President, Portfolio Strategy and Operations @ Tune Therapeutics
Kirkland, WA, US
Nathan Yee's Location
Greater Seattle Area, United States, United States
Nathan Yee's Contact Details

Nathan Yee personal email

n/a

Nathan Yee phone numbers

About Nathan Yee

Cell therapy product development leader withdemonstrated success in leading multifunctional departments and spearheading matrixedproject teams across the entire product lifecycle from early-stage clinicaldevelopment and into registration-enabling filings. Currently accountable for all aspects ofAllogeneic Cell Therapy Technical Development & Operations, including establishingmultigenerational strategy, technical team leadership & engineered T cell productdevelopment, mentorship & employee engagement, executive communication, and earlyCMC-enabling strategy.Assume good intent. Always say "please" and "thank you". Show up and do epic s***.

Nathan Yee's Current Company Details
Tune Therapeutics

Tune Therapeutics

View
Vice President, Portfolio Strategy and Operations
Kirkland, WA, US
Website:
tunetx.com
Employees:
80
Nathan Yee Work Experience Details
  • Tune Therapeutics
    Vice President, Portfolio Strategy And Operations
    Tune Therapeutics
    Kirkland, Wa, Us
  • Tune Therapeutics
    Tune Therapeutics
    Kirkland, Wa, Us
  • Tune Therapeutics
    Sr. Director
    Tune Therapeutics Jan 2022 - Present
    Durham, North Carolina, Us
  • Bristol Myers Squibb
    Director, Allogeneic Cell Therapy Platform Leader
    Bristol Myers Squibb Jan 2020 - Jan 2021
    Lawrence Township, Nj, Us
    Founder and platform architect for Allogeneic Cell Therapy Technical Development group; accountable for technology design, project strategy, and experimental execution of Allo platform products, while serving as the business partner for research, clinical, portfolio strategy and commercial teams. Director-level leader for engineering integration teams, and matrix leaders across multidisciplinary cell therapy CMC functions (analytical development, quality, regulatory, operations, MSAT, etc.) for early assets. Responsible for overall technical and strategic success of the platform, from technology identification/funneling to regulatory filings in order to address unmet medical needs.
  • Celgene
    Associate Director, Allogeneic Cell Thearapy Cmc Product Strategy
    Celgene Aug 2019 - Jan 2021
    Summit, New Jersey, Us
    Founder & product development strategy leader for novel Allogeneic Platform Team. Leveraged portfolio learnings across autologous CAR-T products to derive a production-scale platform for gene-edited T cell therapies - from concept, to technology identification, and end-to-end proof of concept in an accelerated manner. Accessed available resources and adapted a startup mentality to secure budget, apply a rapid-iteration innovation loop, and build a new team of engineers and Ph.D. level scientists. Delivered project collateral (white papers, invention disclosures, technology intelligence reports) that resulted in accelerated sponsorship and enhanced prioritization in the midst of corporate merger dynamics.
  • Juno Therapeutics, Inc.
    Associate Director, Analytical Development - Immunoassays Leader
    Juno Therapeutics, Inc. Apr 2018 - Aug 2019
    Seattle, Wa, Us
    Director-level leader of 18 staff across flow cytometry and cell-based assay analytical development teams, consisting of team leaders, Ph.D. Scientists, and project leaders across 6 clinical stage CAR-T products. Successfully delivered functional deliverables across method development, qualification, transfer, and assay lifecycle strategy for internal and external customers. Authored content for BLA and ex-US regulatory filings for Breyanzi, and CMC Analytical Strategy leader for clinical stage orva-cel program. Also served as facilitator for top-end Technical Development governance team, while actively coaching project teams and bridging communication between programs, corporate governance and senior leaders.
  • Juno Therapeutics, Inc.
    Sr. Scientist, T Cell Product Characterization
    Juno Therapeutics, Inc. Apr 2016 - Apr 2018
    Seattle, Wa, Us
    Co-founded T cell Product Characterization department, and served as Breyanzi analytical product characterization leader. Responsible for MoA, justification of CQAs (critical quality attributes), CMC correlative analysis, and extended characterization strategy & testing logistics. Chaired the CMC correlative analysis team and served as division representative for Neurotoxicity Working Group.
  • Juno Therapeutics, Inc.
    Scientist, Analytical Development & Head Of Assay Support
    Juno Therapeutics, Inc. Mar 2015 - Apr 2016
    Seattle, Wa, Us
    Founded the Assay Support Group, an operations-focused organization responsible for executing analytics for IND-enabling process development. Built new lab, established KPIs, and developed data reporting infrastructure to execute work in support of clinical stage development. Proactively led matrixed assay teams across Analytical Development and Quality Control to optimize assays and increase performance while reducing data turnaround time, with oversight across multiple assays platforms and technologies (ligand-binding assays, flow cytometry, cell based and potency assays, etc.)
  • Juno Therapeutics, Inc.
    Flow Cytometry Scientist, Process And Analytical Development
    Juno Therapeutics, Inc. Apr 2014 - Mar 2015
    Seattle, Wa, Us
  • Snbl Usa
    Senior Scientist & Flow Cytometry Core Lab Supervisor
    Snbl Usa Oct 2012 - Apr 2014
    Kagoshima, Kagoshima, Jp
    - Architect of GLP-compliant flow cytometry core lab services. Designed SOPs and established best practices to efficiently develop and validate functional and phenotyping assays for regulated pre-clinical studies.- Responsible for all aspects of immunotoxicology evaluation, including study design, data analysis/reporting, benchwork, consultation with Sponsors and Study Directors, and mentorship of analytical scientists and technicians. Tasked with long-term strategic planning and operations of immunology services.- Developed cell-based assays to mechanistically interrogate off-target effects, including drug-induced thrombocytopenia. Led multi-departmental effort to correlate developmental, phenotypic and functional endpoints of primary hemostasis for multiple programs.- Extensive experience in multiparameter flow cytometry profiling of all leukocyte populations, with an emphasis on T, B and myeloid cell activation. Adept at interrogating complex and rare populations in NHPs, including CD34+ stem cells and myeloid progenitors in active bone marrow.- Scientific consultant for diverse therapeutic programs with a specific emphasis on regulatory strategy and study design for immunology-related disease models and test articles.- Manager and scientific lead for analytical scientists, technicians and administrative coordinators. Responsible for establishing scientific rationale, planning logistics, scheduling and directing project teams to create assays that comply with FDA/EMA Bioanalytical guidances and FDA/ICH Immunotoxicology guidances.- Author of immunotoxicology articles and posters. Company-selected speaker for a major industry conference.- Awarded SNBL USA 2013 Employee of the Year.
  • Benaroya Research Institute
    Post Doctoral Fellow
    Benaroya Research Institute Jun 2012 - Oct 2012
    Seattle, Wa, Us
  • University Of Washington
    Doctoral Fellow
    University Of Washington Sep 2005 - Jun 2012
    Seattle, Wa, Us
  • University Of Washington
    Research Scientist
    University Of Washington 2004 - 2005
    Seattle, Wa, Us

Nathan Yee Skills

Flow Cytometry Immunology Car T Cells Cancer Immunotherapy Cell Biology Qpcr Pharmaceutical Process Development Animal Models Assay Development Analytical Methods Development Cell Immunoassays Elisa Protein Expression Western Blotting Cell Culture Molecular Biology Glp Immunohistochemistry Pcr Innate Immunity Project Planning Biomarkers Immunotoxicology Immunogenicity Bioanalysis Analytical Method Validation Macrophages Dendritic Cells T Cells

Nathan Yee Education Details

  • University Of Washington - School Of Medicine
    University Of Washington - School Of Medicine
    Immunology
  • University Of Washington
    University Of Washington
    Microbiology
  • University Of Washington
    University Of Washington
    Biochemistry

Frequently Asked Questions about Nathan Yee

What company does Nathan Yee work for?

Nathan Yee works for Tune Therapeutics

What is Nathan Yee's role at the current company?

Nathan Yee's current role is Vice President, Portfolio Strategy and Operations.

What is Nathan Yee's email address?

Nathan Yee's email address is na****@****ics.com

What is Nathan Yee's direct phone number?

Nathan Yee's direct phone number is +120658*****

What schools did Nathan Yee attend?

Nathan Yee attended University Of Washington - School Of Medicine, University Of Washington, University Of Washington.

What skills is Nathan Yee known for?

Nathan Yee has skills like Flow Cytometry, Immunology, Car T Cells, Cancer Immunotherapy, Cell Biology, Qpcr, Pharmaceutical Process Development, Animal Models, Assay Development, Analytical Methods Development, Cell, Immunoassays.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.